SEC Form 4 · accession 0000905718-18-000320
Zomedica Corp. · ZOMDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rampertab Shameze
Officer — Chief Financial Officer · Director
Period of report
Mar 12, 2018
Accepted (ET)
Mar 19, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001684144
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Mar 12, 2018 | M | 176,000 | $0.20 | A | 340,000 | D | |
| Common Shares, without par value | holding | — | — | — | 1,000 | I | By son | |
| Common Shares, without par value | holding | — | — | — | 1,000 | I | By daughter | |
| Common Shares, without par value | holding | — | — | — | 1,000 | I | By son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.20 | Mar 12, 2018 | M | 176,000 | D | Mar 28, 2016 | Apr 21, 2018 | Common Shares, without par value | 176,000 | 0 | D |
Explanation of responses
- F1The options vested upon grant. The option is currently fully vested.